SYNERGY CHC CORP (SNYR)
NASDAQHealth CareMedical - DistributionSnapshot 2026-11-04
$0.01+5.15%
Close 2026-09-28 · 1-day change
NASDAQHealth CareMedical - DistributionSnapshot 2026-11-04
QuarterlyIQ Insights · SNYR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | FY 2022 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | 27.7 | 30.4 | 34.8 | 42.8 | — | 29.4 | 33.8 | 35.6 | 34.8 | 13.5 | 0.0 | — | — |
| Total Revenues | 27.7 | 30.4 | 34.8 | 42.8 | — | — | 33.8 | 35.6 | 34.8 | 13.5 | 0.0 | — | — |
| Cost of Revenues | 9.6 | 10.1 | 11.2 | 10.7 | — | 9.1 | 11.0 | 9.8 | — | — | 0.0 | — | — |
| Gross Profit | 18.1 | 20.3 | 23.6 | 32.1 | — | 20.2 | 22.8 | 25.8 | 24.6 | 8.1 | 0.0 | — | — |
| Operating Expenses & Income | |||||||||||||
| Operating Income | (11.0) | (8.5) | 5.8 | 10.8 | — | (8.0) | (4.9) | 1.8 | 2.9 | 0.5 | (1.0) | — | — |
| Earnings from Continuing Operations | |||||||||||||
| Interest Expense | — | 5.9 | 4.1 | 1.7 | — | — | 1.1 | 1.0 | (1.6) | (1.0) | 0.0 | 0.0 | 0.0 |
| Interest & Investment Income | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | 1.7 | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (4.7) | (3.8) | (3.6) | (4.2) | — | 1.1 | 1.5 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (15.7) | (12.2) | 2.2 | 6.6 | — | (9.1) | (6.4) | 0.8 | 0.1 | (7.1) | (1.0) | — | — |
| Income Tax Expense | 0.1 | 0.1 | 0.1 | 0.2 | — | (0.1) | 0.2 | 0.3 | 0.9 | 0.4 | 0.0 | 0.0 | — |
| Net Income | |||||||||||||
| Net Income | (15.8) | (12.3) | 2.1 | 6.3 | — | (9.2) | (6.2) | 0.5 | (0.8) | (7.5) | (1.0) | (0.0) | (0.0) |
| Per Share | |||||||||||||
| Basic EPS | (1.40) | (1.27) | 0.28 | 0.86 | — | (0.10) | (0.07) | 0.01 | — | — | — | — | — |
| Diluted EPS | (1.40) | (1.27) | 0.28 | 0.86 | — | (0.10) | (0.07) | 0.01 | — | — | — | — | — |
| Revenue per Share | 2.45 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 11.3 | 9.7 | 7.6 | 7.4 | — | 89.9 | 89.9 | 89.2 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 11.3 | 9.7 | 7.6 | 7.4 | — | — | 89.9 | 89.2 | — | — | — | 5.1 | 5.0 |
| Supplemental | |||||||||||||
| EBITDA | — | (8.3) | 5.9 | 10.8 | — | (6.7) | (3.1) | 3.3 | 4.1 | 1.1 | — | — | — |
| EBIT | (11.0) | (8.5) | 5.8 | 10.8 | — | (8.0) | (4.9) | 1.8 | 2.9 | 0.5 | (1.0) | — | — |
| Effective Tax Rate | -0.7% | — | — | 3.6% | — | 1.4% | -3.9% | 38.7% | 637.2% | -5.5% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.